In nondiabetic individuals, hypoglycemia initiates a classic negative ... to the secretion of the counterregulatory hormones, glucagon and epinephrine, which act rapidly to stimulate endogenous ...

Through this important partnership, we can save lives by ensuring individuals with diabetes who are treated with insulin have access to glucagon, preferably a ready-to-use formulation, so they can ...

The FDA approved Gvoke, a ready-to-use glucagon product, for the treatment of severe hypoglycemia in 2019. The format is potentially more convenient than traditional glucagon kits from the likes ...

The two organizations will work together on a campaign to raise awareness about the importance of glucagon. According to the ADA, nearly half of all people with type 1 diabetes suffer from at least ...

But even those who have type 2 diabetes who take medication may be vulnerable to hypoglycemia unawareness, even though their blood sugar levels are more likely to skew high than low. Glucagon kits, ...

Check with your healthcare provider before making major changes to your diet if you have diabetes. Some side effects, like hyperglycemia or hypoglycemia, could be dangerous for people with diabetes.

Severely low blood sugar usually requires a glucagon injection. Speak with a healthcare provider to learn ways to prevent low blood sugar if you have frequent episodes of hypoglycemia.

The research sheds new light on how this enzyme influences glucagon secretion in pancreatic alpha (α) cells, a process crucial for maintaining healthy blood sugar levels. The research ...

Glucagon prescriptions for severe hypoglycemia in Medicaid initially decreased from 2012 to 2018 but increased between 2019 and 2023 following the introduction of newer products. Glucagon ...

a long-acting glucagon-like peptide 1 (GLP-1) receptor antagonist, which is being developed to treat post-bariatric hypoglycemia (PBH). The trial, conducted in healthy volunteers, demonstrated ...

Medically reviewed by Danielle Weiss, MD Insulin overdose symptoms can include confusion, fatigue, irritability, shaking, and ...

Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of ...